Table 1 Clinical outcome at baseline (t1), end of study (t2), and change (t2–t1).

From: Development of decision rules for an adaptive aftercare intervention based on individual symptom courses for agoraphobia patients

Instrument (range)

t1 (n = 49)

t2 (n = 51)

Change (t2–t1; n = 46)

M

SD

M

SD

M

SD

Panic and agoraphobia scale (0–52)

19.41

9.15

21.24

9.89

0.43

7.44

Patient health questionnaire (0–12)

4.96

3.04

5.06

2.83

 − 0.07

2.26

Overall anxiety severity and impairment (0–20)

10.70

4.30

9.67

3.97

 − 1.38

3.20

Mobility inventory (1–5)—alone

2.79

0.81

2.85

0.86

 − 0.02

0.52

Mobility inventory (1–5)—accompanied

2.25

0.65

2.22

0.71

 − 0.06

0.50

Agoraphobic cognitions (1–5)

2.21

0.64

2.26

0.54

0.00

0.46

Body sensations (1–5)

2.94

0.78

2.91

0.67

 − 0.07

0.53

Generalized anxiety (0–21)

9.78

5.10

10.41

4.36

0.37

2.89

Back to article page